Semiconductors
Compare Stocks
2 / 10Stock Comparison
ALAB vs NVDA
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
ALAB vs NVDA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Semiconductors |
| Market Cap | $36.71B | $4.78T |
| Revenue (TTM) | $1.00B | $215.94B |
| Net Income (TTM) | $268M | $120.07B |
| Gross Margin | 76.0% | 71.1% |
| Operating Margin | 22.4% | 60.4% |
| Forward P/E | 86.5x | 23.7x |
| Total Debt | $35M | $11.41B |
| Cash & Equiv. | $168M | $10.61B |
ALAB vs NVDA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 24 | May 26 | Return |
|---|---|---|---|
| Astera Labs, Inc. C… (ALAB) | 100 | 288.5 | +188.5% |
| NVIDIA Corporation (NVDA) | 100 | 220.9 | +120.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALAB vs NVDA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALAB is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 115.1%, EPS growth 290.6%, 3Y rev CAGR 120.2%
- Lower volatility, beta 2.99, Low D/E 2.6%, current ratio 10.24x
- 115.1% revenue growth vs NVDA's 65.5%
NVDA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.73, yield 0.0%
- 224.0% 10Y total return vs ALAB's 247.7%
- Beta 1.73, yield 0.0%, current ratio 3.91x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 115.1% revenue growth vs NVDA's 65.5% | |
| Value | Lower P/E (23.7x vs 86.5x) | |
| Quality / Margins | 55.6% margin vs ALAB's 26.7% | |
| Stability / Safety | Beta 1.73 vs ALAB's 2.99 | |
| Dividends | 0.0% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +198.9% vs NVDA's +72.7% | |
| Efficiency (ROA) | 58.1% ROA vs ALAB's 18.3%, ROIC 81.8% vs 12.3% |
ALAB vs NVDA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALAB vs NVDA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ALAB and NVDA each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $215.9B annually — 215.6x ALAB's $1.0B. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to ALAB's 26.7%. On growth, ALAB holds the edge at +93.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.0B | $215.9B |
| EBITDAEarnings before interest/tax | $230M | $133.2B |
| Net IncomeAfter-tax profit | $268M | $120.1B |
| Free Cash FlowCash after capex | $343M | $96.7B |
| Gross MarginGross profit ÷ Revenue | +76.0% | +71.1% |
| Operating MarginEBIT ÷ Revenue | +22.4% | +60.4% |
| Net MarginNet income ÷ Revenue | +26.7% | +55.6% |
| FCF MarginFCF ÷ Revenue | +34.2% | +44.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.4% | +73.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +144.4% | +97.8% |
Valuation Metrics
NVDA leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 40.1x trailing earnings, NVDA trades at a 77% valuation discount to ALAB's 176.8x P/E. On an enterprise value basis, NVDA's 35.9x EV/EBITDA is more attractive than ALAB's 202.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $36.7B | $4.78T |
| Enterprise ValueMkt cap + debt − cash | $36.6B | $4.78T |
| Trailing P/EPrice ÷ TTM EPS | 176.80x | 40.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 86.46x | 23.74x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.42x |
| EV / EBITDAEnterprise value multiple | 202.94x | 35.85x |
| Price / SalesMarket cap ÷ Revenue | 43.06x | 22.12x |
| Price / BookPrice ÷ Book value/share | 28.40x | 30.52x |
| Price / FCFMarket cap ÷ FCF | 130.30x | 49.40x |
Profitability & Efficiency
Evenly matched — ALAB and NVDA each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $20 for ALAB. ALAB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVDA's 0.07x. On the Piotroski fundamental quality scale (0–9), ALAB scores 5/9 vs NVDA's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +20.3% | +76.3% |
| ROA (TTM)Return on assets | +18.3% | +58.1% |
| ROICReturn on invested capital | +12.3% | +81.8% |
| ROCEReturn on capital employed | +14.7% | +97.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.03x | 0.07x |
| Net DebtTotal debt minus cash | -$132M | $807M |
| Cash & Equiv.Liquid assets | $168M | $10.6B |
| Total DebtShort + long-term debt | $35M | $11.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 545.03x |
Total Returns (Dividends Reinvested)
NVDA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $135,979 today (with dividends reinvested), compared to $34,772 for ALAB. Over the past 12 months, ALAB leads with a +198.9% total return vs NVDA's +72.7%. The 3-year compound annual growth rate (CAGR) favors NVDA at 90.0% vs ALAB's 51.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.1% | +4.1% |
| 1-Year ReturnPast 12 months | +198.9% | +72.7% |
| 3-Year ReturnCumulative with dividends | +247.7% | +585.5% |
| 5-Year ReturnCumulative with dividends | +247.7% | +1259.8% |
| 10-Year ReturnCumulative with dividends | +247.7% | +22397.9% |
| CAGR (3Y)Annualised 3-year return | +51.5% | +90.0% |
Risk & Volatility
NVDA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NVDA is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than ALAB's 2.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 90.6% from its 52-week high vs ALAB's 82.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.99x | 1.73x |
| 52-Week HighHighest price in past year | $262.90 | $216.80 |
| 52-Week LowLowest price in past year | $63.40 | $110.82 |
| % of 52W HighCurrent price vs 52-week peak | +82.0% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 66.4 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 5.0M | 166.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ALAB as "Buy" and NVDA as "Buy". Consensus price targets imply 41.9% upside for NVDA (target: $279) vs -6.8% for ALAB (target: $201).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $201.13 | $278.83 |
| # AnalystsCovering analysts | 15 | 79 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% |
NVDA leads in 3 of 6 categories — strongest in Valuation Metrics and Total Returns. 2 categories are tied.
ALAB vs NVDA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ALAB or NVDA a better buy right now?
For growth investors, Astera Labs, Inc.
Common Stock (ALAB) is the stronger pick with 115. 1% revenue growth year-over-year, versus 65. 5% for NVIDIA Corporation (NVDA). NVIDIA Corporation (NVDA) offers the better valuation at 40. 1x trailing P/E (23. 7x forward), making it the more compelling value choice. Analysts rate Astera Labs, Inc. Common Stock (ALAB) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALAB or NVDA?
On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 40.
1x versus Astera Labs, Inc. Common Stock at 176. 8x. On forward P/E, NVIDIA Corporation is actually cheaper at 23. 7x.
03Which is the better long-term investment — ALAB or NVDA?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1260%, compared to +247.
7% for Astera Labs, Inc. Common Stock (ALAB). Over 10 years, the gap is even starker: NVDA returned +224. 0% versus ALAB's +247. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALAB or NVDA?
By beta (market sensitivity over 5 years), NVIDIA Corporation (NVDA) is the lower-risk stock at 1.
73β versus Astera Labs, Inc. Common Stock's 2. 99β — meaning ALAB is approximately 73% more volatile than NVDA relative to the S&P 500. On balance sheet safety, Astera Labs, Inc. Common Stock (ALAB) carries a lower debt/equity ratio of 3% versus 7% for NVIDIA Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ALAB or NVDA?
By revenue growth (latest reported year), Astera Labs, Inc.
Common Stock (ALAB) is pulling ahead at 115. 1% versus 65. 5% for NVIDIA Corporation (NVDA). On earnings-per-share growth, the picture is similar: Astera Labs, Inc. Common Stock grew EPS 290. 6% year-over-year, compared to 66. 7% for NVIDIA Corporation. Over a 3-year CAGR, ALAB leads at 120. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALAB or NVDA?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus 25. 7% for Astera Labs, Inc. Common Stock — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus 20. 3% for ALAB. At the gross margin level — before operating expenses — ALAB leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALAB or NVDA more undervalued right now?
On forward earnings alone, NVIDIA Corporation (NVDA) trades at 23.
7x forward P/E versus 86. 5x for Astera Labs, Inc. Common Stock — 62. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVDA: 41. 9% to $278. 83.
08Which pays a better dividend — ALAB or NVDA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ALAB or NVDA better for a retirement portfolio?
For long-horizon retirement investors, NVIDIA Corporation (NVDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+224.
0% 10Y return). Astera Labs, Inc. Common Stock (ALAB) carries a higher beta of 2. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NVDA: +224. 0%, ALAB: +247. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALAB and NVDA?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.